(Q28540089)
Statements
High-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferation (English)
Lian-Wang Guo
Bowen Wang
Song Guo
Drew Roenneburg
Gene E Ananiev
24 February 2014
24 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference